EUCTR2012-002175-34-AT进行中（未招募）不适用
Eplerenone on Top of ACE Inhibition in Chronic Kidney Disease Patients with Hypertension (EPOCH) - EPOCH
Med. Univ. Wien, Universitätsklinik f. Innere Medizin III, Abt. f. Nephrologie und Dialyse0 个研究点目标入组 24 人开始时间: 2012年9月14日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Chronic kidney disease stages II-III (defined by MDRD formula)
- •Diabetes mellitus type 2 (defined by WHO criteria)
- •Urinary albumin to creatinine ratio (UACR) >300mg/g, UACR >200mg/g if already receiving RAS blockade
- •Hypertension
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 24
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 24
排除标准
- •Age <18 years
- •UACR >3500mg/g
- •severe hypertension
- •unwilling or unability to sign the informed consent
研究者
相似试验
招募中
3 期
The efficacy of Eplerenon drug in patient with Acute CSCR (Central SerousChorioretinopathy)Central Serous Chorioretinopathy.H35.71Central serous chorioretinopathyIRCT20180825040860N1Esfahan University of Medical Sciences40
招募中
1 期
Evaluation of the effect of Eplerenone in Central serous chorioretinopathy )CSCRCentral serous chorioretinopathyIRCT20220122053792N1Oroumia University of Medical Sciences34
进行中（未招募）
1 期
REMODEL-AMIEUCTR2014-005407-24-CZIKEM
已完成
不适用
Aldosterone blockade in children with chronic allograft nephropathyISRCTN19419571Sectorial Fund for Health Research (Fondo Sectorial de Investigación en Salud) (Mexico)62
已完成
2 期
Eplerenone, ACE Inhibition and AlbuminuriaDiabetic NephropathyNCT00315016Radboud University Medical Center30